Cargando…
Access, excess, and overdiagnosis: the case for thyroid cancer
The incidence of thyroid cancer in women is increasing at an epidemic rate. Numerous studies have proposed that the cause is increasing detection due to availability and use of medical diagnostic ultrasound. Our objective was to compare rates of diagnosis across different health-care regions to rate...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons Ltd
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3930400/ https://www.ncbi.nlm.nih.gov/pubmed/24408145 http://dx.doi.org/10.1002/cam4.184 |
_version_ | 1782304521692643328 |
---|---|
author | Hall, Stephen F Irish, Jonathan Groome, Patti Griffiths, Rebecca |
author_facet | Hall, Stephen F Irish, Jonathan Groome, Patti Griffiths, Rebecca |
author_sort | Hall, Stephen F |
collection | PubMed |
description | The incidence of thyroid cancer in women is increasing at an epidemic rate. Numerous studies have proposed that the cause is increasing detection due to availability and use of medical diagnostic ultrasound. Our objective was to compare rates of diagnosis across different health-care regions to rates of diagnostic tests and to features of both health and access of the regional populations. This is a population-based retrospective ecological observational study of 12,959 patients with thyroid cancer between January 1, 2000 and December 31, 2008 in Ontario Canada based on the health-care utilization regions (Local Health Integration Networks) of the province of Ontario Canada. We found that some regions of Ontario had four times the rates of diagnosis of thyroid cancer compared to other regions. The regions with the highest use of discretionary medical tests (pelvic ultrasound, abdominal ultrasound, neck ultrasound, echocardiogram, resting electrocardiogram, cardiac nuclear perfusion tests, and bone scan), highest population density, and better education had the highest rates of thyroid cancer diagnoses. Differences in the rates of the ordering of discretionary diagnostic medical tests, such as diagnostic ultrasound, in different geographic regions of Ontario lead to differences in the rates of diagnosis of thyroid cancer. |
format | Online Article Text |
id | pubmed-3930400 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | John Wiley & Sons Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-39304002014-03-04 Access, excess, and overdiagnosis: the case for thyroid cancer Hall, Stephen F Irish, Jonathan Groome, Patti Griffiths, Rebecca Cancer Med Original Research The incidence of thyroid cancer in women is increasing at an epidemic rate. Numerous studies have proposed that the cause is increasing detection due to availability and use of medical diagnostic ultrasound. Our objective was to compare rates of diagnosis across different health-care regions to rates of diagnostic tests and to features of both health and access of the regional populations. This is a population-based retrospective ecological observational study of 12,959 patients with thyroid cancer between January 1, 2000 and December 31, 2008 in Ontario Canada based on the health-care utilization regions (Local Health Integration Networks) of the province of Ontario Canada. We found that some regions of Ontario had four times the rates of diagnosis of thyroid cancer compared to other regions. The regions with the highest use of discretionary medical tests (pelvic ultrasound, abdominal ultrasound, neck ultrasound, echocardiogram, resting electrocardiogram, cardiac nuclear perfusion tests, and bone scan), highest population density, and better education had the highest rates of thyroid cancer diagnoses. Differences in the rates of the ordering of discretionary diagnostic medical tests, such as diagnostic ultrasound, in different geographic regions of Ontario lead to differences in the rates of diagnosis of thyroid cancer. John Wiley & Sons Ltd 2014-02 2014-01-10 /pmc/articles/PMC3930400/ /pubmed/24408145 http://dx.doi.org/10.1002/cam4.184 Text en © 2014 The Authors. Cancer Medicine published by John Wiley & Sons Ltd. http://creativecommons.org/licenses/by/3.0/ This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Research Hall, Stephen F Irish, Jonathan Groome, Patti Griffiths, Rebecca Access, excess, and overdiagnosis: the case for thyroid cancer |
title | Access, excess, and overdiagnosis: the case for thyroid cancer |
title_full | Access, excess, and overdiagnosis: the case for thyroid cancer |
title_fullStr | Access, excess, and overdiagnosis: the case for thyroid cancer |
title_full_unstemmed | Access, excess, and overdiagnosis: the case for thyroid cancer |
title_short | Access, excess, and overdiagnosis: the case for thyroid cancer |
title_sort | access, excess, and overdiagnosis: the case for thyroid cancer |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3930400/ https://www.ncbi.nlm.nih.gov/pubmed/24408145 http://dx.doi.org/10.1002/cam4.184 |
work_keys_str_mv | AT hallstephenf accessexcessandoverdiagnosisthecaseforthyroidcancer AT irishjonathan accessexcessandoverdiagnosisthecaseforthyroidcancer AT groomepatti accessexcessandoverdiagnosisthecaseforthyroidcancer AT griffithsrebecca accessexcessandoverdiagnosisthecaseforthyroidcancer |